We are live on ! Find out more
ACET icon

Adicet Bio
ACET

53 hedge funds and large institutions have $266M invested in Adicet Bio in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

163% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 8

129% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 7

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

99% more capital invested

Capital invested by funds: $134M → $266M (+$132M)

20% more funds holding

Funds holding: 44 → 53 (+9)

1% more ownership

Funds ownership: 3.04% → 4.04% (+1%)

Holders
53
Holders Change
+9
Holders Change %
+20.45%
% of All Funds
0.93%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
16
Increased
21
Reduced
8
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
+$32M
2
A
Abingworth
United Kingdom
+$23.2M
3
CCM
Consonance Capital Management
New York
+$17.5M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$15M
5
VA
VR Adviser
New York
+$14.3M

Top Sellers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
-$1.82M
2
IC
Ikarian Capital
Texas
-$562K
3
6CM
683 Capital Management
New York
-$362K
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$349K
5
Morgan Stanley
Morgan Stanley
New York
-$220K
Name Holding Trade Value Shares
Change 		Change in
Stake
ECM
26
ExodusPoint Capital Management
New York
$938K +$348K +1,516 +51%
Goldman Sachs
27
Goldman Sachs
New York
$598K +$510K +2,220 +347%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$560K -$689 -3 -0.1%
Acadian Asset Management
29
Acadian Asset Management
Massachusetts
$542K -$50.3K -219 -8%
MS
30
Maven Securities
Jersey
$489K +$531K +2,312 New
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$425K +$114K +498 +33%
Jacobs Levy Equity Management
32
Jacobs Levy Equity Management
New Jersey
$360K – – –
Citadel Advisors
33
Citadel Advisors
Florida
$355K +$408K +1,776 New
Northern Trust
34
Northern Trust
Illinois
$340K +$373K +1,624 New
BCM
35
Bridgeway Capital Management
Texas
$318K – – –
Renaissance Technologies
36
Renaissance Technologies
New York
$263K +$288K +1,256 New
Jane Street
37
Jane Street
New York
$238K +$261K +1,138 New
BFM
38
Boothbay Fund Management
New York
$230K +$243K +1,060 +67%
Bank of America
39
Bank of America
North Carolina
$196K +$209K +910 +3,250%
Qube Research & Technologies (QRT)
40
Qube Research & Technologies (QRT)
United Kingdom
$177K -$349K -1,522 -64%
GSEP
41
Golden State Equity Partners
California
$172K – – –
Citigroup
42
Citigroup
New York
$153K +$1.61K +7 +1%
State Street
43
State Street
Massachusetts
$137K -$71.1K -310 -32%
TRCT
44
Tower Research Capital (TRC)
New York
$32K +$24.8K +108 +230%
UBS Group
45
UBS Group
Switzerland
$22K +$16.1K +70 +194%
Bank of Montreal
46
Bank of Montreal
Ontario, Canada
$12K – – –
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$11K -$2.07K -9 -16%
PCM
48
Penserra Capital Management
California
$8K +$3.44K +15 +54%
Morgan Stanley
49
Morgan Stanley
New York
$6K -$220K -957 -97%
Fifth Third Bancorp
50
Fifth Third Bancorp
Ohio
$2K – – –
1
2
3

ACET Hedge Fund Activity: Q1 2021 in Review

53 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Adicet Bio (ACET) for Q1 2021, worth a combined $266M — up 99% from $134M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ACET positions and 7 closed out — a net gain of 9 holders — while 21 added to existing stakes and 8 trimmed.

The largest buyer was Avidity Partners Management, opening a new position worth an estimated $32M. The largest seller was Artal Group, exiting entirely with an estimated $1.82M sold.

  • 53 institutional investors held Adicet Bio (ACET) as of Q1 2021, up from 44 in Q4 2020.
  • Funds reported $266M of Adicet Bio stock for Q1 2021, up 99% quarter-over-quarter.
  • 16 funds opened new Adicet Bio positions in Q1 2021 and 7 closed out, a net change of +9 holders.
  • The largest Adicet Bio buyer in Q1 2021 was Avidity Partners Management, an estimated $32M added.
  • The largest Adicet Bio seller in Q1 2021 was Artal Group, an estimated $1.82M sold.

Based on aggregated 13F filings for Q1 2021.